Skip to main content
Atrás
Watch Compare

NP Life Sciences Health Industry Group Inc.

Calidad de datos: 100%
ACAT
OTC Services Educational Services
$1.00
▼ $9.00 (-90.00%)
Cap. Mercado: 77.21 M
Precio
$1.00
Cap. Mercado
77.21 M
Rango del Día
$1.00 — $1.00
Rango de 52 Semanas
$0.54 — $10.00
Volumen
2,500
Apertura $1.00
Promedio 50D / 200D
$10.00
90.00% below
Promedio 50D / 200D
$6.07
83.54% below

Quick Summary

Puntos Clave

ROE of 58.71% indicates high profitability
Generating 55,238.0 in free cash flow
P/E of 2660.93 — premium valuation
Cash machine — converts 190.36% of earnings into free cash flow
ROIC of 34.16% — excellent capital efficiency

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)-38.04%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
58.71%
Above sector avg (-15.95%)
ROIC34.16%
Net Margin14.46%
Op. Margin25.80%

Seguridad

Debt / Equity
N/A
Current RatioN/A
Interest Coverage12943.00

Valoración

PE (TTM)
2660.93
Above sector avg (-1.17)
P/B Ratio2433.04
EV/EBITDA1489.81
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Services (502 pares)
Métrica Acción Mediana del Sector
P/E 2660.9 -1.2
P/B 2433.0 1.4
ROE % 58.7 -16.0
Net Margin % 14.5 -19.4
Rev Growth 5Y % — 4.0
D/E — 0.4

All Fundamental Metrics
Growth
Revenue Growth (1Y) -38.04% Revenue Growth (3Y) 70.73%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 200,634.0 Net Income (TTM) 29,018.0
ROE 58.71% ROA 24.24%
Gross Margin N/A Operating Margin 25.80%
Net Margin 14.46% Free Cash Flow (TTM) 55,238.0
ROIC 34.16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage 12943.00 Asset Turnover 1.68
Working Capital N/A Tangible Book Value 31,736
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 2660.93 Forward P/E N/A
P/B Ratio 2433.04 P/S Ratio 384.85
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 1489.81 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0.07%
Market Cap 77.21 M Enterprise Value 77.13 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 190.36%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2023 FY2021 FY2020 FY2019
Revenue 102,002.0 164,621.0 34,992.0 15,000.0 43,000.0
Net Income -18,856.0 -2,935.0 -65,677.0 -131,065.0 -108,827.0
EPS (Diluted) — 0.00 — — —
Gross Profit — — — — —
Operating Income -18,855.0 -690.0 -65,681.0 -131,091.0 -108,859.0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense -1.0 645.0 — — —
Income Tax — 1,600.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2022 FY2023 FY2021 FY2020 FY2019
Total Assets 127,784.0 76,864.0 38,411.0 118,611.0 250,097.0
Total Liabilities 108,468.0 60,483.0 239.0 14,762.0 15,183.0
Shareholders' Equity 19,316.0 16,381.0 38,172.0 103,849.0 234,914.0
Total Debt — — — — —
Cash & Equivalents 121,859.0 70,614.0 27,986.0 118,611.0 242,933.0
Current Assets — — — — —
Current Liabilities — 38,121.0 — — —